|
|
||||||||
Department of Physiology and Pharmacology and The Hypertension Center, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1083; and Max Delbruck Center for Molecular Medicine, 01115 Berlin-Buch, Germany
| |
ABSTRACT |
|---|
|
|
|---|
We previously
demonstrated that mRen-2 transgenic [Tg(+)] rats are
sensitive to chronic high NaCl intake, showing increased arterial
pressure and vasopressin (VP) secretion. In this study, we determined
the effect of a chronic osmotic challenge, 4 days of drinking 2% NaCl,
on direct arterial blood pressure, heart rate, fluid-electrolyte
balance, circadian rhythm of mean arterial pressure (MAP), and changes
in plasma VP and catecholamines. Under baseline conditions, male Tg(+)
rats showed a significant shift in the peak in circadian MAP into the
light portion of the day-night cycle. Substitution of 2% NaCl for
drinking water caused a rapid increase in MAP, 20 ± 5 mmHg in Tg(+)
rats within 6 h. Whereas the amplitude of circadian MAP fluctuations
increased in salt-loaded Tg(+) rats, there was no significant change in
the circadian timing of peak MAP with salt loading. Tg(+) rats showed
exaggerated osmotic-induced increases in plasma VP, norepinephrine
(NE), and epinephrine (Epi) compared with Tg(
) rats. Plasma NE
and Epi were increased two- and fourfold, respectively, in the
hypertensive rats with no significant change in the Tg(
) rats.
Intravenous administration of a VP antagonist did not alter arterial
pressure in either Tg(+) or Tg(
) rats. Tg(+) and Tg(
)
rats showed a positive sodium balance with no significant difference
observed between the groups. Tg(+) rats showed a significant increase
in salt consumption, plasma sodium, osmolality, and hematocrit,
accompanied by a negative water balance. We conclude that Tg(+) rats
are sensitive to acute and chronic osmotic stimuli in terms of blood
pressure, fluid-electrolyte balance, and plasma VP and catecholamines.
Whereas elevated plasma VP does not contribute to the hypertensive
response, increased sympathetic drive may mediate the salt-induced
blood pressure changes in this model.
hypertension; renin; vasopressin; catecholamines; osmotic challenge
| |
INTRODUCTION |
|---|
|
|
|---|
INCREASED SALT INTAKE has been incriminated as a pathogenic factor in hypertension. There is strong evidence that a genetic predisposition is involved in salt-induced hypertension in human subjects and animal models (12). Thus identification of the genetic factors involved in salt sensitivity would be a major scientific contribution and an aid in prevention and treatment of the disease. A new model of hypertension has been produced by the insertion of the mouse renin gene into the rat genome (36). This Sprague-Dawley-derived strain is characterized by overexpression of both circulating and tissue components of the renin-angiotensin system (RAS). The hypertension in this model is characterized by a shift in the circadian rhythm of arterial pressure with peak pressures seen late in the dark cycle (26). Recently, we have shown that arterial blood pressure in the Tg(+) rat is sensitive to a chronic osmotic challenge produced by forced consumption of 2% NaCl for 4 days, a typical experimental paradigm for producing activation of central peptidergic neurons (10). These hypertensive Tg(+) rats showed increased blood pressure and plasma vasopressin (VP) in response to ingestion of 2% NaCl (10), as well as a reduction in blood pressure produced by sodium depletion (5). Therefore, studies in this genetically engineered model suggest that overactivity of the renin gene causes a salt and/or osmosensitive state, a finding that may be applicable to clinical situations.
A variety of neuroendocrine and physical factors are believed to be involved in salt sensitivity, including sympathetic activation, VP secretion, baroreceptor impairment, and volume status. It has been demonstrated that the sympathetic nervous system is involved in the development of salt-sensitive hypertension in numerous animal models (7, 14, 46, 49). Sharma et al. (44) found that a high-salt diet caused a greater pressor response to norepinephrine (NE) in salt-sensitive than in salt-resistant subjects. VP is another important factor that may contribute to the pathogenesis of salt-sensitive hypertension. VP is a potent vasoconstrictor and an important hormone regulating water and salt balance. Increased secretion of VP has been found in several models of hypertension such as DOCA-salt hypertension, spontaneously hypertensive rats (SHR), and Dahl rats (17, 28, 43). The most convincing evidence for a role of VP in salt-sensitive hypertension is the fact that DOCA-salt hypertension cannot be produced in Brattleboro rats that lack VP (17, 39).
It has been demonstrated that the central RAS plays an important role in the endocrine regulation of blood pressure and electrolyte balance. Injection of ANG II into the central nervous system (CNS) increases arterial pressure via release of VP (23) and activation of the sympathetic nervous system (27). Interestingly, angiotensin peptides and sodium act synergistically to produce exaggerated behavioral and physiological responses (2, 22). Bruner and colleagues (8) were the first to demonstrate that dietary sodium intake could produce a hypertensive response to chronic subpressor CNS infusions of ANG II. Thus overactivity of the RAS in the CNS of the renin transgenic model may cause the exaggeration of VP, sympathetic neural, and cardiovascular responses to osmotic stimulation.
In the present study, a chronic blood pressure-monitoring system was used to examine the effect of salt loading on acute and chronic cardiovascular parameters. Circadian modeling analysis was utilized to determine whether the osmotic challenge would effect a shift in circadian rhythm shown in this model of hypertension and to characterize the rapidity of the osmotically induced pressor response. The mechanisms of increased pressor responsiveness in the mRen-2 transgenic model were explored by evaluating the effects of salt loading on fluid-electrolyte balance and circulating VP and catecholamines. The role of circulating VP in exaggerated osmotic responsiveness of Tg(+) was explored by use of a VP antagonist.
| |
METHODS |
|---|
|
|
|---|
All experiments were carried out in accordance with the Guiding
Principles for the Care and Use of Animals as delineated by the
American Physiological Society. Male 10- to 12-wk-old heterozygous Tg(+) positive for the mRen-2 gene and control Tg(
) rats were used in this study. These transgenic rats were produced by breeding female heterozygous rats with male Hanover Sprague-Dawley controls, the
strain from which the transgenic animals were derived. Genotyping was
used to confirm presence of the transgene, and arterial pressure was
used to confirm the phenotypic expression. The rats were obtained from
the breeding colony established at The Hypertension Center of Wake
Forest University School of Medicine. Animals were housed in either
Nalgene metabolism or regular polycarbonate cages modified by the
attachment of a fluid swivel and a pressure transducer on the top of
the cage. The animals had free access to regular rat chow (1% NaCl)
and either water or 2% NaCl. The vivarium was maintained at
21-22°C with a 12:12-h light-dark cycle (5:00 PM lights off).
In the metabolism study, arterial catheters (PE-60 with a Silastic tip) were inserted into the common carotid artery under xylazine:ketamine anesthesia (5.7:71 mg/kg im). The catheter was tunneled through a protective spring that was attached to a fluid swivel and the animal. Catheter patency was maintained by constant infusion of heparinized saline (50 U/ml, 0.9% NaCl, 1.8 ml/24 h). Food and water intake were determined daily at 4:00 PM and stabilized at presurgery levels during a 5- to 6-day recovery period. Baseline measurement of food and water intake, urinary volume, and sodium output were taken for 2 days. The animals were then switched to 2% NaCl as the sole drinking fluid for 4 days. Indexes of fluid-electrolyte balance (fluid and food intake and urine output) were taken on each day at 4:00 PM.
Arterial blood pressure was monitored by an in-line pressure sensor (model 156 PC 15GWL, Microswitch, Freeport, IL). The signal from the pressure sensor was digitized by a DT2814 analog-to-digital board (Data Translation, Marlborough, MA) and sampled at 3,000 Hz. Arterial pressure and heart rate (HR) were monitored continuously using a program (BP16) developed by Dr. Phillip Hutchins, Wake Forest University School of Medicine, with hourly, 12:12-h light-dark cycle, and 24-h averages of systolic and diastolic pressure, mean arterial pressure (MAP), and HR. Blood samples (1.5 ml) were taken at 10:00 AM on day 1 (basal) and day 5 (the 4th day of salt loading) for measurement of hematocrit and plasma sodium, potassium, osmolality, VP, Epi, and NE. Blood sample was replaced with an equivalent volume of isotonic saline.
In study 2, animals received a jugular
vein catheter (PE-10) in addition to an arterial catheter.
Approximately 7 days after surgery, baseline blood pressure and HR were
taken over a 30-min period between 1:00 and 3:00 PM. Animals were then
given 2% NaCl in place of normal drinking water. On the second and
fourth day after the start of saline ingestion, arterial pressure was
measured and an intravenous bolus infusion of the
V1 VP antagonist
[
-mercapto-
,
-cyclopentamethylenepropionyl1,O-Me-Tyr2,Arg8]VP
(9 µg/100 g body wt) was given to determine whether
circulating VP played a role in the elevation of arterial pressure. The
efficacy of this dose of antagonist was tested in two Tg(+) rats, and
it abolished the 40- and 46-mmHg pressor responses to a bolus arginine vasopressin (AVP) infusion (25 ng/kg iv) in the two animals.
Rhythm analysis for MAP was performed using the nonlinear least-squares fitting program PHARMFIT (29). Twenty-four-hour cosine and all partial Fourier curves, including up to the fifth harmonic (4.8-h period), were fitted as models to the data. The program calculates estimates of midline estimating statistic of rhythm (MESOR, i.e., the rhythm-adjusted 24-h mean), amplitude (half of peak to trough of rhythmic change), and acrophase (peak time of each component cosine function) of the harmonics together with the percentage of rhythm. The F test was used to test for zero amplitude. Model comparison statistics over all fit models were done with the PHARMFIT subprogram SYNOPS according to Wald as described in detail by McIntosh and McIntosh (30). Briefly, likelihood was calculated for each fit model and transformed into a confidence value. Among the models with a confidence of at least 0.05, the mode with the smallest number of harmonics was regarded as best fit.
Daily indexes of sodium balance were computed by subtracting urinary sodium excretion from total sodium (food + 2% NaCl) intake. Fecal electrolyte excretion was not measured because it represents only 1-2% of total sodium output over a range of intakes (32). Plasma sodium and potassium was determined by flame photometry (IL943 Flame Photometer, Lexington, MA) and osmolality by freezing point depression (Fiske One-Ten Osmometer, Fiske Associates, Needham Heights, MA). Plasma samples were extracted using acetone precipitation and petroleum ether extraction for peptide determinations. VP was assayed by a sensitive radioimmunoassay as previously described (11). Plasma NE and Epi were determined by a sensitive radioenzymatic assay with minor modifications of previously published techniques (50).
Statistical analysis was conducted using the SAS statistical package. Data were analyzed by analysis of variance with repeated measures where appropriate. Within-group comparisons were made, where appropriate, using contrast comparisons. Between-group differences were analyzed with Student-Newman-Keuls post hoc test. A significance level of P < 0.05 was used for all comparisons. All values are reported as means ± SE, except as indicated.
| |
RESULTS |
|---|
|
|
|---|
Effect of 2% NaCl consumption on cardiovascular parameters.
Tg(+) rats had significantly higher basal MAP than Tg(
) rats
(142 ± 5 vs. 93 ± 2 mmHg/24 h). When given 2% NaCl as the sole drinking fluid, Tg(+) rats showed a rapid increase in MAP (20 mmHg
within 6 h) compared with the same time period in the previous 24-h
recording (Fig. 1). Arterial blood pressure
was increased in Tg(+) rats throughout the 4-day period of salt loading
(Fig. 2). Salt consumption produced no
change in MAP in Tg(
) rats (Figs. 1 and 2). There was no
significant difference in HR between the two groups, and salt intake
did not significantly affect HR (data not shown).
|
|
) rats (Table 1). Acrophases of the
dominant 24-h period for MAP occurred at 1:30 AM and 1:54 AM in
salt-loaded and water-replete Tg(
) rats, respectively. In
contrast, the acrophases of the dominant 24-h period for MAP in Tg(+)
rats were shortly after the onset of the light phase (6:20 AM for water
replete and 5:30 AM for salt loaded). A further significant improvement
of fit (6-14%) was obtained by including additional harmonics in
the fitting procedure (Table 1, best fit).
|
Effect of 2% NaCl consumption on plasma VP and catecholamines.
There were no differences in the basal levels of plasma NE and Epi
between Tg(
) and Tg(+) rats (Fig.
3). After 4 days of salt loading, there
were significant increases in plasma Epi and NE in Tg(+) rats but no
changes in Tg(
) rats. Basal plasma VP was similar in Tg(+) and
Tg(
) rats, 0.4 ± 0.1 and 0.3 ± 0.2 pg/ml, respectively
(Fig. 4). Plasma VP was increased to 3.9 ± 0.8 and 1.7 ± 0.4 pg/ml in Tg(+) and Tg(
) rats with a
significantly greater response (P < 0.01) observed in Tg(+) rats.
|
|
Effect of 2% NaCl consumption on fluid-electrolyte balance.
There were no differences in basal hematocrit and plasma osmolality and
sodium between Tg(+) and Tg(
) rats (Table
2). Salt loading produced significant
increases in plasma sodium, hematocrit, and osmolality in Tg(+) rats
with no change observed in Tg(
) rats (Table 2). In addition,
plasma potassium was decreased in Tg(+) rats, whereas no change was
observed in Tg(
) subjects. The hypokalemia in Tg(+) rats is
perhaps due to increased arterial pressure eliciting a kaluresis. Over
the 4-day osmotic challenge, Tg(+) rats consumed significantly more 2%
NaCl than Tg(
) rats (see Fig.
6A) and tended
(P < 0.06) to have a greater intake
of sodium (Fig.
5A). The
greater intake of 2% NaCl reached significance only on
day 3 (Fig.
6A).
Both Tg(+) and Tg(
) groups showed positive sodium balance after
consuming 2% NaCl with no significant difference between the groups
(Fig. 5C). Drinking 2% NaCl caused
a significant negative water balance (fluid intake-urine output) in
Tg(+) rats over the 4 days of salt loading with no significant change
observed in Tg(
) rats (Fig.
6C). Over the 4 days of high salt
intake, water balance averaged 4 ± 4 ml in Tg(+) compared with 14 ± 2 ml in Tg(
) rats, indicating a significant loss of body
fluids in the Tg(+) group. High salt intake significantly increased
urine output, with an exaggerated diuresis in Tg(+) rats compared with Tg(
) rats (Fig. 6B).
|
|
|
Effect of VP antagonist on NaCl-induced blood pressure increases.
Consumption of 2% NaCl for 2 or 4 days produced a significant (~30
mmHg) increase in arterial pressure in Tg(+) rats. In contrast, Tg(
) rats showed only a slight (7 mmHg) nonsignificant increase in arterial pressure. Administration of a
V1 VP antagonist had no
significant effect on arterial pressure in Tg(+) or Tg(
) rats after either 2 or 4 days of drinking hypertonic saline
(Table 3).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study presents several original findings: 1) mRen-2 transgenic rats show a rapid increase in arterial pressure when forced to consume excessive NaCl, 2) this increase in arterial pressure does not affect the shift in circadian rhythm of arterial pressure shown by Tg(+) rats, 3) plasma catecholamines are elevated in addition to plasma VP, and 4) plasma VP does not play a role in this pressor response.
A key finding in this study is that Tg(+) rats showed an acute pressor response to the ingestion of a hypertonic saline solution. The blood pressure began to rise rapidly and was significantly elevated by 20 mmHg after 6 h of exposure to 2% NaCl. This finding complements a previous report that showed that sodium depletion (acute furosemide treatment followed by a chronic low-salt diet) caused a rapid and sustained decrease (50 mmHg) in diastolic pressure in Tg(+) rats (5). Recently, Sesoko and colleagues (42) showed that a low-salt diet alone decreased arterial pressure in Tg(+) rats. Furthermore, others have shown that dehydration produces a modest increase (<10 mmHg) in arterial pressure and that restoration of drinking water causes a profound and rapid decrease (25 mmHg within 12 h) in arterial pressure (D. B. Averill, personal communication). These data suggest that overexpression of the mRen-2 gene produces a salt- or osmotic-sensitive state in this transgenic model.
Increased plasma or CNS RAS components in Tg(+) rats may exaggerate the
input of osmotic information from peripheral and/or central
osmoreceptors to effect an acute pressor response to the hypertonic
solution. There is evidence that animals show drinking behavior and
endocrine changes before consumed fluids have produced significant
effects on systemic osmolality (1, 15). Peripheral osmoreceptors are
located in the regions served by the mesenteric and portal circulation.
Morita and colleagues (33) have shown that in dogs consumption of
high-salt chow elicits frank increases in plasma sodium and decreases
in renal nerve activity without altering MAP or plasma AVP.
Osmosensitive information derived from peripheral osmoreceptors is
transmitted to a number of CNS areas involved in autonomic and
neurohumoral regulation, including the area postrema and nucleus
tractus solitarius, lateral parabrachial nucleus, and possibly ventral
medulla (24, 25). Hypertonic stimulation of peripheral osmoreceptors
without a frank elevation in plasma osmolality can also activate the
magnocellular neurosecretory cells of the supraoptic and
paraventricular nuclei and thus increase VP secretion (4, 13, 34).
Although we found that drinking 2% NaCl does not significantly elevate
plasma sodium or osmolality at 6 and 48 h (unpublished observations),
it is possible that small nondetectable increases in portal plasma
sodium or osmolality may occur shortly after exposure to the
hyperosmotic stimulus. This may activate the sympathetic nervous system
and release VP to increase blood pressure and restore fluid-electrolyte
balance in the early period of salt loading. After 4 days of drinking 2% NaCl, plasma sodium and osmolality are elevated in the Tg(+) rats.
Recently, our laboratory found that an equivalent hypertonic saline
load given by either intravenous (37) or intracerebroventricular (unpublished observations) routes elicits greater pressor responses in
Tg(+) rats compared with Tg(
) rats. Because the cardiovascular response to osmotic stimulation is dependent on forebrain osmoreceptive regions, our findings may indicate that the central osmoreceptors in
Tg(+) rats are more sensitive to osmotic challenges.
Alterations in the circadian variation in blood pressure have been
shown to affect cardiovascular morbidity and mortality (35). In
hypertensive populations, failure to show nocturnal decreases in
arterial pressure is associated with microalbuminuria (6) and increases
in left ventricular mass (48). In the present study, we used
continuous, hour-by-hour monitoring of blood pressure to examine the
cardiovascular response to high salt intake in Tg(+) and Tg(
)
rats. Under baseline conditions, the acrophase (peak) in blood pressure
in Tg(+) rats was shifted to about 6:00 AM (shortly after the onset of
the light cycle) compared with Tg(
) rats, which peaked at
approximately 2:00 AM. This finding is similar to that of
Lemmer and colleagues (26, 40), who reported that the acrophase for
arterial pressure was shifted into the early to midpart of the light
cycle in Tg(+) rats. In the current study, the osmotic challenge did
not change the circadian blood pressure pattern in either Tg(+) or
Tg(
) rats but increased MESOR and amplitude in Tg(+) rats. These
results are consistent with the report that high salt intake did not
disrupt the circadian rhythm of blood pressure in either NaCl-sensitive
SHR or NaCl-resistant Wistar-Kyoto rats (9). These findings are
interesting in light of the recent observation that salt-sensitive
hypertensive patients fail to show nocturnal decreases in arterial
pressure compared with non-salt-sensitive patients (47) and suggests a
possible pathophysiological link between salt sensitivity and
alterations in circadian blood pressure control. The manifestations of
that salt sensitivity may be different in human vs. animal subjects because salt-sensitive humans show an absence of diurnal rhythms, whereas mRen-2 transgenic rats show a shift in blood pressure rhythms.
Consistent with a previous report from our laboratory (10), 4 days of drinking 2% NaCl produced elevated levels of plasma VP in Tg(+) rats. Brain RAS is involved in osmotic stimulation of the hypothalamic VP axis (27). Recent studies demonstrated that osmotic-induced VP release was blocked by angiotensin receptor antagonists (21) or antisense directed against angiotensin receptors (31). Senanayake et al. (41) found that Tg(+) rats have elevated levels of angiotensin peptides in brain regions participating in the neuroendocrine regulation of blood pressure, such as hypothalamus and brain stem. Thus the elevated brain RAS in Tg(+) rats may exaggerate the osmotic input, resulting in increased secretion of plasma VP. Increased osmotic-induced levels of plasma VP have been observed in other models of salt-sensitive hypertension (16) and have been shown to play a role in the expression of salt sensitivity in DOCA salt hypertension and acute sinoaortic denervation (18, 38). In the current study, we found that increased plasma VP did not play a role in the arterial pressure response to salt loading in Tg(+) rats. In this respect, these rats resemble Dahl salt-sensitive rats and the elevation of plasma VP may be an attempt to compensate for greater osmotic challenges in Tg(+) rats. Alternatively, the elevation of plasma VP may be a reflection of increased CNS sensitivity to osmotic challenges. We have recently observed that intracerebroventricular injection of hypertonic NaCl produces exaggerated pressor and plasma VP responses in Tg(+) rats (unpublished observations).
Sympathetic activation must also be considered as mediating the
cardiovascular response to the osmotic challenge in Tg(+) rats. Salt
loading produced significant increases in plasma NE and Epi in Tg(+)
but not in Tg(
) rats. A salt-induced increase in plasma
catecholamines has been observed in salt-sensitive subjects and animals
(12). Support for a role of catecholamines in the development of
hypertension is provided by the demonstrations that peripheral
6-hydroxydopamine lesions of catecholamine neurons and neonatal
guanethidine-induced sympathectomy attenuated or prevented the
development of salt-sensitive hypertension (19, 46). Both central ANG
II injection and osmotic stimulation cause an increase in arterial
pressure by activation of sympathetic nervous system (22, 27). The
pressor response to intracerebroventricular ANG II is potentiated by a
NaCl load administered by intravenous infusion or in the diet (3, 8).
Furthermore, Katahira and colleagues (22) showed that reversing the
routes of administration still results in synergistic interaction of
ANG II and NaCl on arterial pressure, which is dependent on activation
of the sympathetic nervous system (22). Thus in Tg(+) rats the
sympathetic output is probably exaggerated by the elevated plasma
sodium/osmolality, and this may be contributing to the elevation of
arterial pressure at this time point. Further studies are needed to
explore the role of sympathetic activation at different time points and
to determine whether alterations in portal sodium receptors mediate these responses at early time points in the response.
There was no significant difference in sodium balance between
salt-loaded Tg(+) and Tg(
) rats. However, only Tg(+) rats
significantly increased hematocrit and plasma sodium and osmolality. In
addition, urine output during salt loading was significantly greater
for Tg(+) rats. During the 4 days of salt loading, Tg(+) rats
demonstrated an overall negative water balance and increased
hematocrit, suggesting that these animals became dehydrated. This fluid
loss could have resulted in higher plasma sodium and osmolality. These
abnormal physiological responses may be related to alterations in renal function in Tg(+) rats. For example, isolated perfused kidneys of Tg(+)
rats show increased renal perfusion flow and GFR, but urinary sodium
excretion is normal, suggesting that the sodium reabsorption is greater
in Tg(+) rats (45). Gross and colleagues (20) reported that the
pressure-diuresis-natriuresis relationship is shifted to higher
pressure levels in Tg(+) rats. Thus pressure natriuresis/diuresis may
play a role in the handling of the osmotic challenge in the transgenic
rats. Indeed, salt-induced increase in blood pressure may have led to a
diuresis in Tg(+) rats.
In conclusion, the genetic overexpression of angiotensin peptides in mRen-2 transgenic rats leads to exaggerated cardiovascular, endocrine, and body fluid-electrolyte responses to acute and chronic osmotic stress. These findings provide further evidence that central angiotensin systems are critical in the regulation of osmotic responsiveness and that the renin gene may be a candidate marker for salt-sensitive hypertension.
| |
ACKNOWLEDGEMENTS |
|---|
The authors thank Dr. N. Alexander for measuring plasma catecholamines.
| |
FOOTNOTES |
|---|
This research was supported by National Heart, Lung, and Blood Institute Grants HL-51592 and HL-43178 and American Heart Association North Carolina Affiliate Grants NC93-GS-15 and NC95-GS-34.
Address for reprint requests: M. F. Callahan, Dept. of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157-1083.
Received 25 September 1997; accepted in final form 15 May 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adolph, E. F.
Termination of drinking: satiation.
Federation Proc.
41:
2533-2535,
1982[Medline].
2.
Andersson, B.,
and
O. Westbye.
Synergistic action of sodium and angiotensin on brain mechanisms controlling water and salt balance.
Nature
288:
75,
1970.
3.
Ando, K.,
Y. Sato,
and
T. Fujita.
Salt sensitivity in hypertensive rats with angiotensin II administration.
Am. J. Physiol.
259 (Regulatory Integrative Comp. Physiol. 28):
R1012-R1016,
1990
4.
Arsenijevic, Y.,
and
A. J. Baertschi.
Activation of the hypothalamo-neurohypophysial system by hypertonic superfusion of the rat mesentery.
Brain Res.
347:
169-172,
1985[Medline].
5.
Barrett, G. L.,
and
J. J. Mullins.
Studies on blood pressure regulation in hypertensive ren-2 transgenic rats.
Kidney Int. Suppl.
41:
S125-S128,
1992.
6.
Bianchi, S.,
G. Bigazzi,
G. Sgherri,
and
V. M. Campese.
Diurnal variations of blood pressure and microalbuminuria in essential hypertension.
Am. J. Hypertens.
7:
23-29,
1994[Medline].
7.
Bouvier, M.,
and
J. de Champlain.
Increased sympathoadrenal tone and adrenal medulla reactivity in DOCA-salt hypertensive rats.
J. Hypertens.
4:
157-163,
1986[Medline].
8.
Bruner, C. A.,
J. M. Weaver,
and
G. D. Fink.
Sodium-dependent hypertension produced by chronic central angiotensin II infusion.
Am. J. Physiol.
249 (Heart Circ. Physiol. 18):
H321-H327,
1985.
9.
Calhoun, D. A.,
S. Zhu,
J. M. Wyss,
and
S. Oparil.
Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats.
Hypertension
24:
1-7,
1994
10.
Callahan, M. F.,
P. Li,
C. M. Ferrario,
D. Ganten,
and
M. Morris.
Salt sensitive hypertension in (mRen-2)27 transgenic rats.
Hypertension
27:
573-577,
1996
11.
Callahan, M. F.,
C. R. Thore,
D. K. Sundberg,
K. A. Gruber,
K. O'Steen,
and
M. Morris.
Excitotoxin paraventricular nucleus lesions: stress and endocrine reactivity and oxytocin mRNA levels.
Brain Res.
597:
8-15,
1992[Medline].
12.
Campese, V. M.
Salt sensitivity in hypertension. Renal and cardiovascular implications.
Hypertension
23:
531-550,
1994
13.
Car, H.,
A. Beitz,
and
J. W. Osborn.
Intragastric hypertonic saline increases vasopressin and central fos immunoreactivity in conscious rats.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R750-R765,
1997
14.
Chen, Y. F.,
Q. C. Meng,
J. M. Wyss,
H. Jin,
and
S. Oparil.
High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats.
Hypertension
11:
55-62,
1988
15.
Choi-Kwon, S.,
and
A. J. Baertschi.
Splanchnic osmosensation and vasopressin: mechanisms and neural pathways.
Am. J. Physiol.
261 (Endocrinol. Metab. 24):
E18-E25,
1991
16.
Cowley, A. W.,
and
J. F. Liard.
Vasopressin and arterial pressure regulation.
Hypertension
11:
I25-I32,
1988.
17.
Crofton, J. T.,
L. Share,
R. E. Shade,
W. J. Lee-Kwon,
M. Manning,
and
W. H. Sawyer.
The importance of vasopressin in the development and maintenance of DOCA-salt hypertension in the rat.
Hypertension
1:
31-38,
1979
18.
Crofton, J. T.,
L. Share,
B. C. Wang,
and
R. E. Shade.
Pressor responsiveness to vasopressin in the rat with DOCA-salt hypertension.
Hypertension
2:
424-431,
1980
19.
Friedman, R.,
L. M. Tassinari,
M. Heine,
and
J. Iwai.
Differential development of salt-induced and renal hypertension in Dahl hypertension-sensitive rats after neonatal sympathectomy.
Clin. Exp. Hypertens.
1:
779-799,
1979.
20.
Gross, V.,
R. J. Roman,
and
A. W. Cowley, Jr.
Abnormal pressure-natriuresis in transgenic renin gene rats.
J. Hypertens.
12:
1029-1034,
1994[Medline].
21.
Hogarty, D. C.,
D. N. Tran,
and
M. I. Phillips.
Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin.
Brain Res.
637:
126-132,
1994[Medline].
22.
Katahira, K.,
H. Mikami,
T. Ogihara,
K. Kohara,
A. Otsuka,
Y. Kumahara,
and
M. C. Khosla.
Synergism of intraventricular NaCl infusion and subpressor angiotensins in rats.
Am. J. Physiol.
256 (Heart Circ. Physiol. 25):
H1-H8,
1989
23.
Keil, L. C.,
J. Summy-Long,
and
W. B. Severs.
Release of vasopressin by angiotensin II.
Endocrinology
96:
1063-1065,
1975
24.
King, M. S.,
and
A. J. Baertschi.
Ventral pontine catecholaminergic pathway mediates the vasopressin response to splanchnic osmostimulation in conscious rats.
Brain Res.
580:
81-91,
1992[Medline].
25.
Kobashi, M.,
and
A. Adachi.
Convergence of hepatic osmoreceptive inputs on sodium-responsive units within the nucleus of the solitary tract of the rat.
J. Neurophysiol.
54:
212-219,
1985
26.
Lemmer, B.,
A. Mattes,
M. Bohm,
and
D. Ganten.
Circadian blood pressure variation in transgenic hypertensive rats.
Hypertension
22:
97-101,
1993
27.
Mann, J. F. E.,
W. Rascher,
A. Schoming,
T. Buu,
O. Kuchel,
R. Boucher,
and
J. Genest.
Contributions of the sympathetic nervous system to the centrally-induced pressor action of angiotensin II in rats.
Clin. Exp. Pharmacol. Physiol.
9:
193-201,
1992.
28.
Matsuguchi, H.,
P. G. Schmid,
D. Van Orden,
and
A. L. Mark.
Does vasopressin contribute to salt-induced hypertension in the Dahl strain?
Hypertension
3:
174-181,
1981
29.
Mattes, A.,
K. Witte,
W. Hohmann,
and
B. Lemmer.
PHARMFIT
a nonlinear fitting program for pharmacology.
Chronobiol. Int.
8:
460-476,
1991[Medline].
30.
McIntosh, J. E. A.,
and
R. P. McIntosh.
Mathematical Modeling and Computers in Endocrinology. New York: Springer, 1980.
31.
Meng, H.,
D. Wielbo,
R. Gyurko,
and
M. I. Phillips.
Antisense oligonucleotide to AT1 receptor mRNA inhibits central angiotensin induced thirst and vasopressin.
Regul. Pept.
54:
543-551,
1994[Medline].
32.
Möhring, J.,
and
B. Möhring.
Evaluation of sodium and potassium balance in rats.
J. Appl. Physiol.
33:
688-692,
1972
33.
Morita, H.,
T. Matsuda,
F. Furuya,
M. R. Khanchowdhury,
and
H. Hosomi.
Hepatorenal reflex plays an important role in natriuresis after high-NaCl food intake in conscious dogs.
Circ. Res.
72:
552-559,
1993
34.
Morita, H.,
Y. Yamashita,
Y. Nishida,
M. Tokuda,
O. Hatase,
and
H. Hosomi.
Fos induction in rat brain neurons after stimulation of the hepatoportal Na-sensitive mechanism.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R913-R923,
1997
35.
Muller, J. E.,
G. H. Tofler,
and
P. H. Stone.
Circadian variation and triggers of acute cardiovascular disease.
Circulation
79:
733-743,
1989
36.
Mullins, J. J.,
J. Peters,
and
D. Ganten.
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.
Nature
344:
541-544,
1990[Medline].
37.
Nishioka, T.,
M. Morris,
P. Li,
C. M. Ferrario,
D. Ganten,
and
M. F. Callahan.
Role of angiotensin AT-2 receptors in the pressor response to osmotic stimulation in the mREN-2 transgenic rat.
Am. J. Hypertens.
11:
357-362,
1998[Medline].
38.
Ryuzaki, M.,
H. Suzuki,
K. Kumagai,
H. Kumagai,
M. Ichikawa,
and
Y. Matsumura.
Role of vasopressin in salt-induced hypertension in baroreceptor-denervated uninephrectomized rabbits.
Hypertension
17:
1085-1091,
1991
39.
Saito, T.,
and
Y. Yajima.
Development of DOCA-salt hypertension in the Battleboro rat.
Ann. NY Acad. Sci.
394:
309-317,
1982[Medline].
40.
Schnecko, A.,
K. Witte,
and
B. Lemmer.
Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
J. Cardiovasc. Pharmacol.
26:
214-221,
1995[Medline].
41.
Senanayake, P. de,
A. Moriguchi,
H. Kumagai,
D. Ganten,
C. M. Ferrario,
and
K. B. Brosnihan.
Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats.
Peptides
15:
919-926,
1994[Medline].
42.
Sesoko, S.,
D. B. Averill,
D. Ganten,
D. I. Diz,
and
C. M. Ferrario.
Blood pressure of mren-2 rats is a function of salt intake.
Soc. Neurosci. Abstr.
22:
854,
1996.
43.
Share, L.,
and
J. T. Crofton.
Contribution of vasopressin to hypertension.
Hypertension
4:
III85-III92,
1982.
44.
Sharma, A. M.,
S. Schattenfroth,
H. M. Thiede,
W. Oelkers,
and
A. Distler.
Effect of sodium salts on pressor reactivity in salt-sensitive men.
Hypertension
19:
541-548,
1992
45.
Springate, J. E.,
L. G. Feld,
and
D. Ganten.
Renal function in hypertensive rats transgenic for mouse renin gene.
Am. J. Physiol.
266 (Renal Fluid Electrolyte Physiol. 35):
F731-F737,
1994
46.
Takeshita, A.,
A. L. Mark,
and
M. J. Brody.
Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine.
Am. J. Physiol.
236 (Heart Circ. Physiol. 5):
H48-H52,
1979.
47.
Uzu, T.,
F. S. Kazembe,
K. Ishikawa,
S. Nakamura,
T. Inenaga,
and
G. Kimura.
High sodium sensitivity implicates nocturnal hypertension in essential hypertension.
Hypertension
28:
139-142,
1996
48.
Verdecchia, P.,
G. Schillaci,
M. Guerrieri,
C. Gatteschi,
G. Benemio,
F. Boldrini,
and
C. Porcellati.
Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension.
Circulation
81:
528-536,
1990
49.
Wyss, J. M.,
Y. F. Chen,
H. Jin,
R. Gist,
and
S. Oparil.
Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after salt loading.
Hypertension
10:
313-320,
1987
50.
Yoneda, S.,
N. Alexander,
and
N. D. Vlachakis.
Enzymatic deconjugation of catecholamines in human and rat plasma and red blood cell lysate.
Life Sci.
33:
935-942,
1983[Medline].
This article has been cited by other articles:
![]() |
N. Li, L. Chen, F. Yi, M. Xia, and P.-L. Li Salt-Sensitive Hypertension Induced by Decoy of Transcription Factor Hypoxia-Inducible Factor-1{alpha} in the Renal Medulla Circ. Res., May 9, 2008; 102(9): 1101 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Chappell, L. M. Yamaleyeva, and B. M. Westwood Estrogen and salt sensitivity in the female mRen(2).Lewis rat Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1557 - R1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Blendea, D. Jacobs, C. S. Stump, S. I. McFarlane, C. Ogrin, G. Bahtyiar, S. Stas, P. Kumar, Q. Sha, C. M. Ferrario, et al. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E353 - E359. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Fang, S. H. Carlson, N. Peng, and J. M. Wyss Circadian rhythm of plasma sodium is disrupted in spontaneously hypertensive rats fed a high-NaCl diet Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1490 - R1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, S. H. Sur, R. E. Mistlberger, and M. Morris Circadian blood pressure and heart rate rhythms in mice Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R500 - R504. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |